Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 179M 536M 156M 144M 134M 254M 17.05B 258M 1.73B 670M 8.36B 672M 658M 28.81B | P/E 2024 |
-4.01x | P/E 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 315M 945M 276M 253M 236M 447M 30.03B 455M 3.05B 1.18B 14.73B 1.18B 1.16B 50.75B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
75.95% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2019-12-23 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 2020-02-29 |
Itai Kabiljo
LAW | General Counsel | - | 2022-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 2015-09-02 | |
David Salton
BRD | Director/Board Member | 66 | 2014-12-13 |
| Chairman | 55 | 2025-02-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 62.14M | |
| -2.01% | +5.98% | +57.26% | +225.65% | 227M | |
| +0.35% | +7.41% | -21.20% | -27.50% | 143M | |
| +3.98% | +18.06% | +29.79% | +103.33% | 122M | |
| -7.84% | +6.82% | +40.30% | -24.19% | 104M | |
| +4.47% | -3.27% | +53.08% | -3.15% | 88.87M | |
| Average | -0.14% | +7.28% | +31.85% | +54.83% | 137.09M | |
| Weighted average by Cap. | -0.43% | +7.58% | +32.86% | +83.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 715M 209M 192M 179M 339M 22.74B 345M 2.31B 894M 11.15B 897M 877M 38.43B | 270M 809M 236M 217M 202M 383M 25.72B 390M 2.61B 1.01B 12.62B 1.01B 992M 43.47B |
| Net income | -67.8M -203M -59.24M -54.4M -50.73M -96.17M -6.45B -97.79M -655M -254M -3.17B -255M -249M -10.91B | -35.71M -107M -31.2M -28.65M -26.72M -50.66M -3.4B -51.51M -345M -134M -1.67B -134M -131M -5.75B |
| Net Debt | 133M 398M 116M 107M 99.34M 188M 12.64B 191M 1.28B 497M 6.2B 498M 488M 21.36B | 136M 408M 119M 109M 102M 193M 12.98B 197M 1.32B 510M 6.37B 512M 501M 21.94B |
Employees
-
